Literature DB >> 33714050

Targeting biofilms using phages and their enzymes.

Joana Azeredo1, Pilar García2, Zuzanna Drulis-Kawa3.   

Abstract

The complex biofilm architecture composed of extracellular polymeric structures (EPS) provides a protective shield to physiologically diverse bacterial cells immersed in its structure. The evolutionary interplay between bacteria and their viruses (phages) forced the latter ones to develop specific strategies to overcome the biofilm defensive barriers and kill sessile cells. Phages are equipped with a wide panel of enzyme-degrading EPS macromolecules which together are powerful weapons to combat biofilms. Antibiofilm performance can be achieved by combining phages or phage-borne enzymes with other antimicrobials such as antibiotics. Nevertheless, a variety of enzymes encoded in phage genomes still need to be explored. To advance in biofilm control strategies we must deepen the understanding of the biofilm biology itself, as well as discover and better exploit the unlimited antibacterial potential of phages.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2021        PMID: 33714050     DOI: 10.1016/j.copbio.2021.02.002

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  7 in total

Review 1.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

Review 2.  Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review.

Authors:  Siyu Liu; Hongyun Lu; Shengliang Zhang; Ying Shi; Qihe Chen
Journal:  Pharmaceutics       Date:  2022-02-16       Impact factor: 6.321

3.  Isolation and Molecular Characterization of a Novel Lytic Bacteriophage That Inactivates MDR Klebsiella pneumoniae Strains.

Authors:  Victor M Balcão; Fernanda C Moreli; Erica C Silva; Bianca G Belline; Layla F Martins; Fernando P N Rossi; Carla Pereira; Marta M D C Vila; Aline M da Silva
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

Review 4.  Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review.

Authors:  Muluneh Assefa; Azanaw Amare
Journal:  Infect Drug Resist       Date:  2022-08-31       Impact factor: 4.177

5.  E. coli biofilm formation and its susceptibility towards T4 bacteriophages studied in a continuously operating mixing - tubular bioreactor system.

Authors:  Ana Lisac; Elfi Birsa; Aleš Podgornik
Journal:  Microb Biotechnol       Date:  2022-05-31       Impact factor: 6.575

Review 6.  Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application.

Authors:  Katarzyna M Danis-Wlodarczyk; Daniel J Wozniak; Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2021-12-06

7.  Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium.

Authors:  Katherine Lev; Ashlan J Kunz Coyne; Razieh Kebriaei; Taylor Morrisette; Kyle Stamper; Dana J Holger; Gregory S Canfield; Breck A Duerkop; Cesar A Arias; Michael J Rybak
Journal:  Antibiotics (Basel)       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.